JP2024524613A5 - - Google Patents

Info

Publication number
JP2024524613A5
JP2024524613A5 JP2024501118A JP2024501118A JP2024524613A5 JP 2024524613 A5 JP2024524613 A5 JP 2024524613A5 JP 2024501118 A JP2024501118 A JP 2024501118A JP 2024501118 A JP2024501118 A JP 2024501118A JP 2024524613 A5 JP2024524613 A5 JP 2024524613A5
Authority
JP
Japan
Prior art keywords
optionally substituted
optionally
prodrug
independently
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024501118A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024524613A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/037196 external-priority patent/WO2023288015A1/en
Publication of JP2024524613A publication Critical patent/JP2024524613A/ja
Publication of JP2024524613A5 publication Critical patent/JP2024524613A5/ja
Pending legal-status Critical Current

Links

JP2024501118A 2021-07-14 2022-07-14 M6pr細胞表面受容体結合化合物及びコンジュゲート Pending JP2024524613A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163221915P 2021-07-14 2021-07-14
US63/221,915 2021-07-14
PCT/US2022/037196 WO2023288015A1 (en) 2021-07-14 2022-07-14 M6pr cell surface receptor binding compounds and conjugates

Publications (2)

Publication Number Publication Date
JP2024524613A JP2024524613A (ja) 2024-07-05
JP2024524613A5 true JP2024524613A5 (cg-RX-API-DMAC7.html) 2025-07-23

Family

ID=82786881

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024501118A Pending JP2024524613A (ja) 2021-07-14 2022-07-14 M6pr細胞表面受容体結合化合物及びコンジュゲート

Country Status (7)

Country Link
US (1) US20240335544A1 (cg-RX-API-DMAC7.html)
EP (1) EP4370156A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024524613A (cg-RX-API-DMAC7.html)
CN (1) CN117915956A (cg-RX-API-DMAC7.html)
AU (1) AU2022310346A1 (cg-RX-API-DMAC7.html)
CA (1) CA3226268A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023288015A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024524614A (ja) 2021-07-14 2024-07-05 ライシア セラピューティクス, インコーポレイテッド Asgpr細胞表面受容体結合化合物及びコンジュゲート
EP4651904A1 (en) 2023-01-18 2025-11-26 Lycia Therapeutics, Inc. Lysosomal targeting bifunctional molecules for degradation of autoantibodies
EP4651901A1 (en) 2023-01-18 2025-11-26 Lycia Therapeutics, Inc. Cycling lysosomal targeting antibody conjugates
WO2024155748A1 (en) * 2023-01-18 2024-07-25 Lycia Therapeutics, Inc. M6pr binding compounds and conjugates
WO2024182772A2 (en) * 2023-03-02 2024-09-06 Avilar Therapeutics, Inc. Mannose 6-phosphate receptor binding compounds for the degradation of extracellular proteins
FR3149188A1 (fr) * 2023-05-31 2024-12-06 Nanomedsyn Pro-ligands, conjugués comprenant lesdits pro-ligands et leurs utilisations pour des applications thérapeutiques
WO2025021155A1 (zh) * 2023-07-25 2025-01-30 深圳湾实验室 一种多特异性结合蛋白及其应用
WO2026015664A1 (en) 2024-07-10 2026-01-15 Lycia Therapeutics, Inc. Cycling lysosomal targeting chimeras targeting immunoglobulin e (ige)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002368077B2 (en) 2001-07-12 2010-03-04 Jefferson Foote Super humanized antibodies
PT1628987E (pt) * 2003-05-20 2009-10-29 Pharmaxis Pty Ltd Compostos manose-6-fosfonato para o tratamento de doenças inflamatórias
TR201808537T4 (tr) 2004-09-23 2018-07-23 Genentech Inc Sistein değiştirilmiş antikorlar ve konjugatlar.
HUE061339T2 (hu) 2014-03-19 2023-06-28 Genzyme Corp Targetáló csoportok helyspecifikus glikotechnikai átalakítása
PL3204425T3 (pl) 2014-10-09 2021-03-08 Genzyme Corporation Glikomodyfikowane koniugaty przeciwciał z lekami
FR3041345B1 (fr) * 2015-09-18 2019-06-14 Nanomedsyn Composes polysaccharides multi-fonctionnalises et leur utilisation pour cibler le recepteur du mannose 6-phosphate cation-independant
BR112018069147A2 (pt) * 2016-03-23 2019-01-22 Fimbrion Therapeutics Inc composto da fórmula iii, composição farmacêutica, método de inibição da função de fimh e método de tratamento de uma doença mediada por fimh
EP3301175A1 (en) * 2016-09-30 2018-04-04 Rijksuniversiteit Groningen Means and methods for mobilizing hematopoietic stem cells (hscs)
EP3897747A4 (en) 2018-12-19 2022-12-07 The Board of Trustees of the Leland Stanford Junior University BIFUNCTIONAL MOLECULES FOR LYSOSOMA TARGETING AND RELATED COMPOSITIONS AND METHODS
US20230051872A1 (en) 2019-03-22 2023-02-16 Reflexion Pharmaceuticals, Inc. Multivalent D-Peptidic Compounds for Target Proteins
EP3941580A1 (en) 2019-03-22 2022-01-26 Reflexion Pharmaceuticals, Inc. D-peptidic compounds for vegf
EP4087584A4 (en) * 2020-01-10 2024-08-28 Lycia Therapeutics, Inc. Cell surface receptor binding compounds and conjugates
US20230226214A1 (en) * 2020-06-24 2023-07-20 Lycia Therapeutics, Inc. Bifunctional bridging compositions for viral transduction
EP4171658A4 (en) * 2020-06-24 2025-04-09 Lycia Therapeutics, Inc. Modified viral compositions for viral transduction

Similar Documents

Publication Publication Date Title
JP2023512455A5 (cg-RX-API-DMAC7.html)
JP2024524614A5 (cg-RX-API-DMAC7.html)
JP7488003B2 (ja) 治療において使用するためのスルファミドリンカーを含むバイオコンジュゲート
JP7381478B2 (ja) 単一分子量ポリサルコシンを含むリガンド-薬物-複合体
DE69426811T2 (de) Polyaminierte Liganden, Metallkomplexe, Verfahren zur Herstellung und diagnostische und therapeutische Verwendungen
JP5866301B2 (ja) 増殖及びタンパク質合成の細胞内ターゲッティングのためのポリアニオン性多価高分子
US20230158155A1 (en) Cell Surface Receptor Binding Compounds and Conjugates
JP4573916B2 (ja) トランスフェリン、アルブミン及びポリエチレングリコールの抗腫瘍性の複合体
CN109310765A (zh) 抗体-药物偶联物
JP2022512643A5 (cg-RX-API-DMAC7.html)
US20090234105A1 (en) Construction of a Multivalent SCFV Through Alkyne-Azide 1,3-Dipolar Cycloaddition
JP2022533215A5 (cg-RX-API-DMAC7.html)
WO2020145228A1 (ja) 配位子及びCEACAM5抗体Fabフラグメントからなる複合体
JP2024524613A (ja) M6pr細胞表面受容体結合化合物及びコンジュゲート
JP2010519182A (ja) 多量体接合体
JP2023542295A5 (cg-RX-API-DMAC7.html)
TW201841660A (zh) 接合單元及包含接合單元之分子構建體
WO2014089247A2 (en) Modular polymer hydrogel nanoparticles and methods of their manufacture
JP2023529640A (ja) 治療用コンジュゲート
JP2025512735A5 (cg-RX-API-DMAC7.html)
JP2019517591A (ja) αvβ3インテグリン甲状腺アンタゴニストにコンジュゲートした非開裂性ポリマー
JP7733664B2 (ja) Epi-x4系ペプチドおよびその誘導体
WO2023032995A1 (ja) 化合物及びこれを用いた標識生体物質
JP2012508231A (ja) 血管内造影剤
AU2024310580A1 (en) Cucurbituril derivatives for radiolabeling, processes of production and uses thereof